Melissari E, Thye C, Scully M F, Kakkar V V
Thrombosis Research Unit, King's College School of Medicine and Dentistry, London, UK.
Thromb Haemost. 1989 Apr 25;61(2):262-5.
Measurement of heparin ex vivo is usually with reference to standard curve prepared with a "spiked" normal human plasma pool (NHP). When the calibration curve was prepared by addition of heparin to whole blood before plasma separation, although the linear relationship was maintained the slope was increased in comparison to the classical standard calibration curve. It is concluded that the preparation of the calibration curve by addition of heparin to NHP may give erroneously high heparin levels in treated patients' plasma, leading perhaps to inappropriate dosage. It was also observed that when heparin was added to blood of different haematocrit (prepared by addition of washed RBC to plasma) and plasma prepared, the subsequent APTT was decreased with the fall in haematocrit; suggesting that the laboratory monitoring of heparin treatment should take into account the patient's haematocrit.
肝素的体外测量通常参照用“加标”正常人血浆池(NHP)制备的标准曲线。当通过在血浆分离前向全血中添加肝素制备校准曲线时,尽管保持了线性关系,但与经典标准校准曲线相比斜率增加。得出的结论是,通过向NHP中添加肝素制备校准曲线可能会使治疗患者血浆中的肝素水平出现错误的高值,这可能导致用药剂量不当。还观察到,当向不同血细胞比容的血液(通过向血浆中添加洗涤后的红细胞制备)中添加肝素并制备血浆时,随后的活化部分凝血活酶时间(APTT)随血细胞比容的降低而降低;这表明肝素治疗的实验室监测应考虑患者的血细胞比容。